Target intelligence / Profile preview

SRY-box transcription factor 30 (SOX30)

Target
SOX30
Molecular classification
Transcription factor
01

Overview

SRY-box transcription factor 30 (SOX30) is a member of the SOX (SRY-related HMG-box) family of transcription factors characterized by a DNA-binding HMG box domain[1][7]. SOX30 acts as both a transcriptional activator and repressor, binding to specific DNA motifs to regulate the expression of target genes. In mammals, SOX30 is essential for male germ cell development, being highly and specifically expressed in meiotic and post-meiotic testicular germ cells, especially during spermatogenesis[1][4][6]. Disruption or deletion of SOX30 in mice leads to impaired spermatogenesis, resulting in male infertility due to arrest during the transition from late meiotic to postmeiotic germ cell stages[1][4][6]. SOX30 additionally plays roles in the regulation of genes involved in cell fate determination and development, such as activating p53 transcription to promote tumor cell apoptosis in certain cancer contexts[7]. SOX30 can inhibit Wnt signaling by directly binding to and suppressing transcription of CTNNB1 (β-catenin), and by binding the CTNNB1 protein to block its interaction with TCF7L2/TCF4[7]. Its function is predominantly specific to the testis in adults, with limited expression in other tissues[1][5]. There are no approved drugs or therapeutic interventions targeting SOX30 directly, and it is not currently considered a conventional therapeutic target such as a receptor or enzyme.

Other names
Transcription factor SOX-30SRY-box 30Sox30 protein type IISOX30
02

Biological functions

Regulation of embryonic developmentCell fate determinationSpermatogenesisTranscriptional regulationRegulation of cell proliferation and differentiationActivation of postmeiotic genes
03

Disease associations

Male infertilityCancer (notably as an activator of apoptosis in lung cancer)Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome

Beyond the preview

Go deeper on SRY-box transcription factor 30 (SOX30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRY-box transcription factor 30 (SOX30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call